Author： Jones T.
Publisher： Informa Healthcare
ISSN： 1472-8214
Source： Expert Opinion on Emerging Drugs, Vol.6, Iss.1, 2001-04, pp. : 95-109
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
HMG-CoA Reductase Inhibitors as Immunomodulators: Potential Use in Transplant Rejection
By Raggatt L.J. Partridge N.C.
Drugs, Vol. 62, Iss. 15, 2002-01 ,pp. :
Access to resources
Recommend
HMG-CoA Reductase Inhibitors in the Prevention of Stroke
Drugs, Vol. 59, Iss. 1, 2000-01 ,pp. :
Comparative Tolerability of the HMG-CoA Reductase Inhibitors
By Farmer J.A. Torre-Amione G.
Drug Safety, Vol. 23, Iss. 3, 2000-09 ,pp. :
Inhibitors of HMG-CoA Reductase: Current and Future Prospects
Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 11, 2009-01 ,pp. :